04/02/2024 3:10 PM | Bretz Charles Luther (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:10 PM | GLAUSER STEVEN JERRY (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:11 PM | Stearn Leathem S (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 3:11 PM | Singh Gurvinder Pal (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 3:36 PM | Organicell Regenerative Medicine (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
12/20/2023 5:30 AM | Organicell Regenerative Medicine (Filer)
| Form DEF 14C | |
12/12/2023 3:15 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 4:00 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2023 3:29 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/19/2023 5:56 AM | Organicell Regenerative Medicine (Filer)
| Form PRER14C | |
09/28/2023 1:54 PM | Organicell Regenerative Medicine (Filer)
| Form PRE 14C | |
09/14/2023 3:15 PM | Organicell Regenerative Medicine (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/11/2023 4:00 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2023 3:15 PM | Organicell Regenerative Medicine (Issuer) Skycrest Holdings, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 8:00 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2023 7:45 AM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/09/2023 3:35 PM | Leider Harry L. (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/09/2023 3:35 PM | Golub Howard Lawrence (Reporting) Organicell Regenerative Medicine (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
06/06/2023 3:53 PM | Organicell Regenerative Medicine (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |